Drug
Gadofosveset trisodium clinical trials
Also written Ablavar, gadofosveset and Vasovist.
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2014 | 1 |
| 2016 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 7
Maastricht University Medical Center (2) · Paul Finn (1) · Northwestern University (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Duke University (1) · Bayer (1) · Guy's Hospital (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses gadofosveset trisodium is read from its arms, and is right about nine times in ten.
Testing it · 8
- Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart DiseaseCompletedPhase 4Paul FinnNCT02752191Written as gadofosveset
- Absolute Quantification of Coronary Flow Reserve by Stress Perfusion MRICompletedPhase 2Northwestern UniversityNCT01655043Written as gadofoveset trisodium
- Imaging of Totally Blocked ArteriesCompletedPhase 1National Heart, Lung, and Blood Institute (NHLBI)NCT00459446Written as MS-325 Injection (Gadofosveset Trisodium)
- Nodal Staging in Breast Cancer With MRLTerminatedNot applicableMaastricht University Medical CenterNCT01609920Written as Gadofosveset enhanced MRL of axillary lymph nodes
- Magnetic Resonance Imaging for Lymph Node Staging in Ovarian CancerWithdrawnPhase 4Maastricht University Medical CenterNCT02243059Written as Gadofosveset trisodium (Ablavar™ )
- Dose-varied Evaluation of Ablavar-enhanced MR Angiography of the Central Veins of the Chest in Healthy ParticipantsCompletedNot applicableDuke UniversityNCT01431300Written as gadofosveset
- Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery DiseaseCompletedPhase 3BayerNCT00296855Written as Vasovist (BAY86-5283, MS-325)
- Improved Diagnosis of Congenital Heart Disease by Magnetic Resonance Imaging Using VasovistStatus unknownPhase 4Guy's HospitalNCT00668824Written as Vasovist
Given in every arm · 1 — gadofosveset trisodium is usual care beside what is tested
As the comparator · 1 — what is tested is compared with gadofosveset trisodium
Codes
What other systems call gadofosveset trisodium · ClinicalTrials.gg INT004039
- MeSH (NLM) C109932gadofosveset trisodiumOne source NLM
- UNII (FDA) XM33Q67UVHGADOFOSVESET TRISODIUMConfirmed FDA, NLM
- RxNorm 1364289One source FDA
- NCI Thesaurus C81057Gadofosveset TrisodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C109932 | gadofosveset trisodium | One source NLM |
| UNII (FDA) | XM33Q67UVH | GADOFOSVESET TRISODIUM | Confirmed FDA, NLM |
| RxNorm | 1364289 | — | One source FDA |
| NCI Thesaurus | C81057 | Gadofosveset Trisodium | One source FDA |
Also registered as gadofosveset (UNII E65RW73PHS · RxNorm 1364290).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.